The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells

Evelyne Zeira; Rinat Abramovitch; Karen Meir; Sharona Even Ram; Yaniv Gil; Baruch Bulvik; Zohar Bromberg; Or Levkovitch; Nathalie Nahmansson; Revital Adar; Benjamin Reubinoff; Eithan Galun; Michal Gropp

doi:10.18632/oncotarget.5787

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells

Evelyne Zeira, Rinat Abramovitch, Karen Meir, Sharona Even Ram, Yaniv Gil, Baruch Bulvik, Zohar Bromberg, Or Levkovitch, Nathalie Nahmansson, Revital Adar, Benjamin Reubinoff, Eithan Galun and Michal Gropp _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:34691-34703. https://doi.org/10.18632/oncotarget.5787

Metrics: PDF 1713 views | HTML 2621 views | ?

Abstract

Evelyne Zeira1, Rinat Abramovitch1, Karen Meir2, Sharona Even Ram1,3, Yaniv Gil1,3, Baruch Bulvik1, Zohar Bromberg1, Or Levkovitch1, Nathalie Nahmansson1, Revital Adar1, Benjamin Reubinoff1,3, Eithan Galun1,* and Michal Gropp1,3,*

1 The Goldyne Savad Institute of Gene Therapy, Hadassah Hebrew University Medical Center, Jerusalem, Israel

2 The Department of Pathology, Hadassah University Hospital, Jerusalem, Israel

3 The Sydney and Judy Swartz Human Embryonic Stem Cell Research Center, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

* These authors have contributed equally to this work

Correspondence to:

Michal Gropp, email:

Eithan Galun, email:

Keywords: H19lncRNA, oncogenesis, pluripotency, hEC cells

Received: August 26, 2015 Accepted: August 31, 2015 Published: September 22, 2015

Abstract

The function of imprinted H19 long non-coding RNA is still controversial. It is highly expressed in early embryogenesis and decreases after birth and re-expressed in cancer. To study the role of H19 in oncogenesis and pluripotency, we down-regulated H19 expression in vitro and in vivo in pluripotent human embryonic carcinoma (hEC) and embryonic stem (hES) cells. H19 knockdown resulted in a decrease in the expression of the pluripotency markers Oct4, Nanog, TRA-1-60 and TRA-1-81, and in the up-regulation of SSEA1; it further attenuated cell proliferation, decreased cell-matrix attachment, and up-regulated E-Cadherin expression. SCID-Beige mice transplanted with H19 down-regulated hEC cells exhibited slower kinetics of tumor formation, resulting in an increased animal survival. Tumors derived from H19 down-regulated cells showed a decrease in the expression of pluripotency markers and up-regulation of SSEA-1 and E-cadherin. Our results suggest that H19 oncogenicity in hEC cells is mediated through the regulation of the pluripotency state.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5787

Publication Alerts

Research Papers:

The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells

Abstract